Amedisys (NASDAQ:AMED) dropped 4.1% after the proposed divestiture buyer in its planned sale to UnitedHealth (UNH) had a ...

Deutsche Bank raised the firm’s price target on UnitedHealth (UNH) to $625 from $595 and keeps a Buy rating on the shares ahead of Wednesday’s ...

Amedisys drops after legal judgement against proposed buyer in UnitedHealth sale. VitalCaring must pay Enhabit with future ...

Researchers analyze the prices on drugs negotiated by Medicare, in comparison to what they cost in other countries. Other Medicare news relates to Medicare Advantage ratings, open enrollment, and ...

Taxpayers paid for their care at the VA—and for Medicare Advantage coverage that many didn’t use. ‘I don’t think I’ve used my ...

Some UnitedHealthcare and Centene Medicare Advantage plans boast higher star ratings after Centers for Medicare and Medicaid ...

La., came out of the efforts of a working group focused on protecting medical institutions from digital attacks.

Insurers tout value based care, we round up hospital finances, and regulators have an eye on vertical integration.

The answer to the question about whether it’s appropriate to call one of President-elect Trump’s latest cabinet nominees by ...

We recently published a list of Top 8 Stocks To Buy In 8 Different Sectors for the Next 3 Months. In this article, we are ...

Analyst Erin Wright of Morgan Stanley maintained a Buy rating on UnitedHealth (UNH – Research Report), retaining the price target of ...